Archive for the ‘Irritable Bowel Syndrome’ Category
Study Finds Structural Brain Alterations In Patients With Irritable Bowel Syndrome
July 23rd, 2010 Posted 1:00 am
A large academic study has demonstrated structural changes in specific brain regions in female patients with irritable bowel syndrome (IBS), a condition that causes pain and discomfort in the abdomen, along with diarrhea, constipation or both. A collaborative effort between UCLA and Canada’s McGill University, the study appears in the July issue of the journal Gastroenterology…
Posted in Irritable Bowel Syndrome
A Guide For Vaccinating The IBD Patient; Findings On Impact Of Gluten-Free Diet In Adult Celiac Patients
June 23rd, 2010 Posted 1:00 am
A guide for vaccinating the Inflammatory Bowel Disease patient, and studies looking at the impact of a gluten-free diet on adults with celiac disease and the relationship between cognitive factors and treatment response in patients with functional bowel disorders, like IBS, are among the highlights of the June issue of The American Journal of Gastroenterology…
Posted in Irritable Bowel Syndrome
Lubiprostone Successfully Completes Phase 3 Efficacy Trial In Japanese Patients Suffering From Chronic Idiopathic Constipation
June 9th, 2010 Posted 11:00 pm
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) and Abbott (NYSE:ABT) today announced that a pivotal phase 3 clinical trial of lubiprostone for chronic idiopathic constipation (CIC) in Japanese patients met its primary endpoint with statistical significance and demonstrated a safety profile consistent with previously reported clinical lubiprostone data…
Posted in Irritable Bowel Syndrome
Symptoms Of Digestive Disorders Alleviated By Probiotic Found In Breast Milk
June 3rd, 2010 Posted 11:00 pm
New research published in the FASEB Journal suggests that Lactobacillus reuteri immediately affects nerves in the gut, explaining how probiotics work Here’s another reason to breast feed your baby: Canadian researchers have discovered how a probiotic found in breastmilk reduces or eliminates painful cramping in the gut…
Posted in Irritable Bowel Syndrome
Narrow-Band Imaging A Useful Tool To Detect In Vivo Angiogenesis In IBD Patients
May 21st, 2010 Posted 4:00 am
Angiogenesis plays a crucial role in neoplastic and non-neoplastic chronic inflammatory disorders, including inflammatory bowel diseases (IBD). Several reports have shown that blockade of angiogenesis in preclinical models of IBD is a promising new therapeutic approach. Visualize angiogenesis in vivo may represent the first step for such a therapeutic approach…
Posted in Irritable Bowel Syndrome
Can Choir Singing Improve Irritable Bowel Syndrome?
May 19th, 2010 Posted 1:00 am
A Swedish investigation has compared choir singing and group discussion in irritable bowel syndrome in the current issue of Psychotherapy and Psychosomatics. Singing in a choir is very popular in the Nordic countries. This activity has been associated with increased longevity, and it induces feelings of relaxation and energy…
Posted in Irritable Bowel Syndrome
Even The Most Severe Symptoms Rapidly Relieved By Self-Directed Behavioral IBS Treatment
May 13th, 2010 Posted 4:00 am
Nearly one-third of patients with irritable bowel syndrome (IBS) who underwent a novel behavior treatment developed by a University at Buffalo behavioral scientist achieved significant relief within four weeks of beginning treatment…
Posted in Irritable Bowel Syndrome
Lexicon Presents Positive Outcome In IBS Patients Treated With LX1031 And Data Supporting Mechanism Of Action
May 7th, 2010 Posted 1:00 am
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, presented results from its positive Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS) at Digestive Disease Week (DDW) 2010 in New Orleans, Louisiana…
Posted in Irritable Bowel Syndrome
Albireo Announces Positive Results From A Study With A3309 In Patients With Chronic Constipation
April 30th, 2010 Posted 2:00 am
Albireo announced that additional clinical data will be reported from a recent study assessing the safety, tolerability and efficacy of A3309 in patients with chronic constipation. A3309 is a first-in-class investigational compound for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC)…
Posted in Irritable Bowel Syndrome
Rome Foundation Introduces Clinical Tool For Diagnosis Of Functional Gastrointestinal Disorders
April 7th, 2010 Posted 12:00 am
New clinical algorithms will give physicians a practical, efficient and cost-effective aid to diagnose the frequent gastrointestinal symptoms that patients commonly bring to their primary care doctors and gastroenterologists–symptoms of functional GI disorders that are often difficult to diagnose…
Posted in Irritable Bowel Syndrome